Recall: HelloLife Neuroveen, Respitrol, Thyroveev And Compulsin
On 2018-08-29, the FDA announced that HelloLife is conducting a recall on Neuroveen, Respitrol, Thyroveev And Compulsin due to possible contamination with microbial. The recalled products were sold under the brand name(s) HelloLife during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 13 drugs recalls due to potential contamination, including all nasal products and baby oral gels, homeopathic products for human and animal use and more. Additionally, there have been 16 drug and medical device recalls due to other health hazards as well as 70 food recalls.
Company Contact Information:
Phone: 1-616-803- 7243
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Neuroveen, Respitrol, Thyroveev and Compulsin
Brand Name(s): HelloLife
Reason for Recall: Microbial Contamination
Official Recall Date: 2018-08-29
Additional information provided by the FDA.gov:
HelloLife, Inc. in Grand Rapids, MI is initiating a voluntary recall of four different products, Neuroveen, Respitrol, Thyroveev and Compulsin, within expiry, to the retail and consumer level due to possible microbial contamination. Neuroveen has been tested and found to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin has been identified as containing Burkholderia cepacia. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.